Hiroyoshi Mori

Showing 1-3 of 3 articles

Coronary interventions

Thromboresistance and functional healing in the COBRA PzF stent versus competitor DES: implications for dual antiplatelet therapy

Jinnouchi H, Mori H, Cheng Q, Kutyna M, Torii S, Sakamoto A, Guo L, Acampado E, Gupta A, Kolodgie F, Virmani R, Finn A

July 19, 2019 | 10.4244/EIJ-D-18-00740

Stents and scaffolds

Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents

Torii S, Cheng Q, Mori H, Lipinski M, Acampado E, Perkins L, Hossainy SF, Pacetti S, Kolodgie F, Virmani R, Finn A

March 20, 2019 | 10.4244/EIJ-D-17-00728

Coronary interventions

Pathological aspects of bioresorbable stent implantation

Sanchez O, Yahagi K, Byrne R, Mori H, Zarpak R, Wittchow E, Foin N, Virmani R, Joner M

May 19, 2015 | 10.4244/EIJV11SVA39

1

Latest news

State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI

EBC 15th consensus document

Save the date: 19th April at 6pm (CET). Join us on Twitter for the 2nd edition

This Week's JAA's: Deep Learning Model to Detect AMI, Mortality After Bleeding vs MI in CAD Patients...

New update: EXAMINATION 10 years, BIONYX 2 years, SAFE A, MASH and more

(Thanks to the support of Biotronik)

Randomised Comparison between POT and KBT: PROPOT Trial

Yusuke Watanabe et al.

Similar long-term outcome of dissimilar drug-eluting stents: is it time to change the assessment?

Clemens von Birgelen et al.

Optimising Physiological Endpoints of Percutaneous Coronary Intervention

Valvular disease